nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—ABCB1—hematologic cancer	0.0454	1	CbGaD
Nicardipine—CYP2B6—Thiotepa—hematologic cancer	0.0188	0.0357	CbGbCtD
Nicardipine—CYP2E1—Thalidomide—hematologic cancer	0.0123	0.0233	CbGbCtD
Nicardipine—CYP2C9—Bexarotene—hematologic cancer	0.012	0.0227	CbGbCtD
Nicardipine—ABCB1—Lenalidomide—hematologic cancer	0.0117	0.0221	CbGbCtD
Nicardipine—CYP2B6—Ifosfamide—hematologic cancer	0.0107	0.0202	CbGbCtD
Nicardipine—CYP2E1—Dacarbazine—hematologic cancer	0.0106	0.02	CbGbCtD
Nicardipine—CYP2C8—Bortezomib—hematologic cancer	0.0106	0.02	CbGbCtD
Nicardipine—CYP3A5—Daunorubicin—hematologic cancer	0.0105	0.0199	CbGbCtD
Nicardipine—CYP2D6—Lomustine—hematologic cancer	0.0102	0.0193	CbGbCtD
Nicardipine—CYP2C9—Idarubicin—hematologic cancer	0.00995	0.0188	CbGbCtD
Nicardipine—CYP3A5—Thalidomide—hematologic cancer	0.00956	0.0181	CbGbCtD
Nicardipine—CYP2B6—Nilotinib—hematologic cancer	0.00928	0.0176	CbGbCtD
Nicardipine—CYP3A5—Teniposide—hematologic cancer	0.00912	0.0173	CbGbCtD
Nicardipine—CYP2D6—Idarubicin—hematologic cancer	0.0091	0.0172	CbGbCtD
Nicardipine—CYP2C19—Bortezomib—hematologic cancer	0.00885	0.0168	CbGbCtD
Nicardipine—CYP3A5—Ifosfamide—hematologic cancer	0.00842	0.0159	CbGbCtD
Nicardipine—CYP2E1—Mitoxantrone—hematologic cancer	0.00821	0.0156	CbGbCtD
Nicardipine—CYP2C8—Ifosfamide—hematologic cancer	0.00809	0.0153	CbGbCtD
Nicardipine—CYP3A5—Imatinib—hematologic cancer	0.00804	0.0152	CbGbCtD
Nicardipine—CYP2D6—Hydroxyurea—hematologic cancer	0.00774	0.0147	CbGbCtD
Nicardipine—CYP2C19—Thalidomide—hematologic cancer	0.00771	0.0146	CbGbCtD
Nicardipine—CYP2C9—Bortezomib—hematologic cancer	0.00736	0.0139	CbGbCtD
Nicardipine—CYP2C19—Teniposide—hematologic cancer	0.00736	0.0139	CbGbCtD
Nicardipine—CYP2C8—Nilotinib—hematologic cancer	0.00703	0.0133	CbGbCtD
Nicardipine—CYP3A4—Bexarotene—hematologic cancer	0.00698	0.0132	CbGbCtD
Nicardipine—ABCB1—Daunorubicin—hematologic cancer	0.00683	0.0129	CbGbCtD
Nicardipine—CYP2C19—Ifosfamide—hematologic cancer	0.00679	0.0129	CbGbCtD
Nicardipine—CYP2D6—Bortezomib—hematologic cancer	0.00673	0.0127	CbGbCtD
Nicardipine—ABCB1—Alitretinoin—hematologic cancer	0.00669	0.0127	CbGbCtD
Nicardipine—CYP3A4—Lomustine—hematologic cancer	0.00649	0.0123	CbGbCtD
Nicardipine—CYP3A4—Busulfan—hematologic cancer	0.00649	0.0123	CbGbCtD
Nicardipine—CYP2C19—Imatinib—hematologic cancer	0.00649	0.0123	CbGbCtD
Nicardipine—CYP3A5—Dasatinib—hematologic cancer	0.00646	0.0122	CbGbCtD
Nicardipine—CYP2C9—Thalidomide—hematologic cancer	0.00641	0.0121	CbGbCtD
Nicardipine—CYP2B6—Irinotecan—hematologic cancer	0.00638	0.0121	CbGbCtD
Nicardipine—CYP2C9—Teniposide—hematologic cancer	0.00612	0.0116	CbGbCtD
Nicardipine—CYP3A4—Thiotepa—hematologic cancer	0.00579	0.011	CbGbCtD
Nicardipine—CYP2C9—Ifosfamide—hematologic cancer	0.00565	0.0107	CbGbCtD
Nicardipine—CYP2C9—Imatinib—hematologic cancer	0.00539	0.0102	CbGbCtD
Nicardipine—ABCB1—Imatinib—hematologic cancer	0.00523	0.00991	CbGbCtD
Nicardipine—CYP2B6—Cisplatin—hematologic cancer	0.0052	0.00985	CbGbCtD
Nicardipine—CYP2E1—Etoposide—hematologic cancer	0.00518	0.00981	CbGbCtD
Nicardipine—CYP3A5—Irinotecan—hematologic cancer	0.00502	0.00951	CbGbCtD
Nicardipine—CYP2D6—Imatinib—hematologic cancer	0.00493	0.00934	CbGbCtD
Nicardipine—CYP2C9—Nilotinib—hematologic cancer	0.0049	0.00928	CbGbCtD
Nicardipine—ABCB1—Nilotinib—hematologic cancer	0.00476	0.00901	CbGbCtD
Nicardipine—ABCB1—Vinorelbine—hematologic cancer	0.00472	0.00893	CbGbCtD
Nicardipine—CYP3A4—Methoxsalen—hematologic cancer	0.0045	0.00852	CbGbCtD
Nicardipine—CYP2D6—Nilotinib—hematologic cancer	0.00448	0.00849	CbGbCtD
Nicardipine—CYP2D6—Vinorelbine—hematologic cancer	0.00444	0.00842	CbGbCtD
Nicardipine—CYP3A5—Vincristine—hematologic cancer	0.00439	0.00832	CbGbCtD
Nicardipine—CYP3A4—Bortezomib—hematologic cancer	0.00428	0.00811	CbGbCtD
Nicardipine—CYP2C19—Prednisone—hematologic cancer	0.00427	0.0081	CbGbCtD
Nicardipine—CYP2E1—Dexamethasone—hematologic cancer	0.00426	0.00806	CbGbCtD
Nicardipine—ABCB1—Dasatinib—hematologic cancer	0.0042	0.00796	CbGbCtD
Nicardipine—CYP2B6—Dexamethasone—hematologic cancer	0.0042	0.00795	CbGbCtD
Nicardipine—ABCB1—Mitoxantrone—hematologic cancer	0.00415	0.00786	CbGbCtD
Nicardipine—CYP3A4—Daunorubicin—hematologic cancer	0.00409	0.00775	CbGbCtD
Nicardipine—CYP3A5—Etoposide—hematologic cancer	0.00402	0.00762	CbGbCtD
Nicardipine—CYP2C8—Etoposide—hematologic cancer	0.00387	0.00733	CbGbCtD
Nicardipine—ABCB1—Betamethasone—hematologic cancer	0.0037	0.00701	CbGbCtD
Nicardipine—ABCB1—Gemcitabine—hematologic cancer	0.00367	0.00695	CbGbCtD
Nicardipine—ABCB1—Prednisolone—hematologic cancer	0.00365	0.00692	CbGbCtD
Nicardipine—CYP3A4—Cytarabine—hematologic cancer	0.00361	0.00684	CbGbCtD
Nicardipine—CYP3A4—Teniposide—hematologic cancer	0.00356	0.00674	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—hematologic cancer	0.00348	0.0066	CbGbCtD
Nicardipine—ABCB1—Prednisone—hematologic cancer	0.00345	0.00653	CbGbCtD
Nicardipine—CYP3A5—Dexamethasone—hematologic cancer	0.00331	0.00627	CbGbCtD
Nicardipine—CYP3A4—Ifosfamide—hematologic cancer	0.00328	0.00622	CbGbCtD
Nicardipine—ABCB1—Irinotecan—hematologic cancer	0.00327	0.00619	CbGbCtD
Nicardipine—CYP2C8—Dexamethasone—hematologic cancer	0.00318	0.00602	CbGbCtD
Nicardipine—CYP3A4—Imatinib—hematologic cancer	0.00314	0.00594	CbGbCtD
Nicardipine—CYP3A4—Ruxolitinib—hematologic cancer	0.00295	0.00559	CbGbCtD
Nicardipine—ABCB1—Vinblastine—hematologic cancer	0.00291	0.00551	CbGbCtD
Nicardipine—ABCB1—Vincristine—hematologic cancer	0.00286	0.00541	CbGbCtD
Nicardipine—CYP3A4—Nilotinib—hematologic cancer	0.00285	0.0054	CbGbCtD
Nicardipine—CYP3A4—Vinorelbine—hematologic cancer	0.00283	0.00535	CbGbCtD
Nicardipine—CYP2C9—Cisplatin—hematologic cancer	0.00275	0.0052	CbGbCtD
Nicardipine—CYP2D6—Vinblastine—hematologic cancer	0.00274	0.00519	CbGbCtD
Nicardipine—CYP2C19—Dexamethasone—hematologic cancer	0.00267	0.00505	CbGbCtD
Nicardipine—ABCB1—Cisplatin—hematologic cancer	0.00267	0.00505	CbGbCtD
Nicardipine—ABCB1—Etoposide—hematologic cancer	0.00262	0.00496	CbGbCtD
Nicardipine—CYP3A4—Triamcinolone—hematologic cancer	0.00258	0.0049	CbGbCtD
Nicardipine—CYP3A4—Dasatinib—hematologic cancer	0.00252	0.00477	CbGbCtD
Nicardipine—CYP3A4—Mitoxantrone—hematologic cancer	0.00249	0.00471	CbGbCtD
Nicardipine—CYP2C9—Dexamethasone—hematologic cancer	0.00222	0.0042	CbGbCtD
Nicardipine—CYP3A4—Betamethasone—hematologic cancer	0.00222	0.0042	CbGbCtD
Nicardipine—CYP3A4—Prednisolone—hematologic cancer	0.00219	0.00414	CbGbCtD
Nicardipine—ABCB1—Dexamethasone—hematologic cancer	0.00215	0.00408	CbGbCtD
Nicardipine—CYP3A4—Prednisone—hematologic cancer	0.00207	0.00391	CbGbCtD
Nicardipine—CYP2D6—Dexamethasone—hematologic cancer	0.00203	0.00384	CbGbCtD
Nicardipine—CYP3A4—Irinotecan—hematologic cancer	0.00196	0.00371	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—hematologic cancer	0.00179	0.00338	CbGbCtD
Nicardipine—CYP3A4—Vinblastine—hematologic cancer	0.00174	0.0033	CbGbCtD
Nicardipine—PDE1B—gonad—hematologic cancer	0.00174	0.0412	CbGeAlD
Nicardipine—ABCB1—Methotrexate—hematologic cancer	0.00173	0.00328	CbGbCtD
Nicardipine—CYP3A4—Vincristine—hematologic cancer	0.00171	0.00324	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—hematologic cancer	0.00168	0.00319	CbGbCtD
Nicardipine—CYP3A4—Etoposide—hematologic cancer	0.00157	0.00297	CbGbCtD
Nicardipine—PDE1B—blood—hematologic cancer	0.00151	0.0359	CbGeAlD
Nicardipine—PDE1A—gonad—hematologic cancer	0.00146	0.0345	CbGeAlD
Nicardipine—CYP3A4—Dexamethasone—hematologic cancer	0.00129	0.00244	CbGbCtD
Nicardipine—PDE1B—testis—hematologic cancer	0.00125	0.0297	CbGeAlD
Nicardipine—PDE1A—lung—hematologic cancer	0.00111	0.0264	CbGeAlD
Nicardipine—CYP3A4—Doxorubicin—hematologic cancer	0.00107	0.00203	CbGbCtD
Nicardipine—PDE1A—testis—hematologic cancer	0.00105	0.0249	CbGeAlD
Nicardipine—CHRM4—testis—hematologic cancer	0.00096	0.0227	CbGeAlD
Nicardipine—PDE1B—lymph node—hematologic cancer	0.000908	0.0215	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—hematologic cancer	0.00085	0.0201	CbGeAlD
Nicardipine—CACNB2—lung—hematologic cancer	0.00082	0.0194	CbGeAlD
Nicardipine—CACNB2—testis—hematologic cancer	0.000774	0.0183	CbGeAlD
Nicardipine—CACNA2D1—lung—hematologic cancer	0.00077	0.0183	CbGeAlD
Nicardipine—PDE1A—lymph node—hematologic cancer	0.000761	0.018	CbGeAlD
Nicardipine—CALM2—hematopoietic system—hematologic cancer	0.000749	0.0178	CbGeAlD
Nicardipine—CALM1—hematopoietic system—hematologic cancer	0.000746	0.0177	CbGeAlD
Nicardipine—CACNA2D1—testis—hematologic cancer	0.000727	0.0172	CbGeAlD
Nicardipine—CACNA1D—lung—hematologic cancer	0.000717	0.017	CbGeAlD
Nicardipine—CYP2C19—hematopoietic system—hematologic cancer	0.000712	0.0169	CbGeAlD
Nicardipine—ADRA1A—hematopoietic system—hematologic cancer	0.000703	0.0167	CbGeAlD
Nicardipine—CACNA1D—testis—hematologic cancer	0.000676	0.016	CbGeAlD
Nicardipine—CACNA1C—lung—hematologic cancer	0.000662	0.0157	CbGeAlD
Nicardipine—CALM3—blood—hematologic cancer	0.000632	0.015	CbGeAlD
Nicardipine—CACNA1C—testis—hematologic cancer	0.000624	0.0148	CbGeAlD
Nicardipine—CYP2C8—hematopoietic system—hematologic cancer	0.000621	0.0147	CbGeAlD
Nicardipine—CALM3—bone marrow—hematologic cancer	0.000612	0.0145	CbGeAlD
Nicardipine—CALM2—gonad—hematologic cancer	0.00057	0.0135	CbGeAlD
Nicardipine—CALM1—gonad—hematologic cancer	0.000567	0.0134	CbGeAlD
Nicardipine—CACNB2—lymph node—hematologic cancer	0.000561	0.0133	CbGeAlD
Nicardipine—CYP3A5—hematopoietic system—hematologic cancer	0.000561	0.0133	CbGeAlD
Nicardipine—CYP2B6—hematopoietic system—hematologic cancer	0.000557	0.0132	CbGeAlD
Nicardipine—CALM3—lung—hematologic cancer	0.000554	0.0131	CbGeAlD
Nicardipine—CYP2C9—hematopoietic system—hematologic cancer	0.000552	0.0131	CbGeAlD
Nicardipine—CACNA2D1—lymph node—hematologic cancer	0.000527	0.0125	CbGeAlD
Nicardipine—CALM3—testis—hematologic cancer	0.000523	0.0124	CbGeAlD
Nicardipine—CYP2E1—hematopoietic system—hematologic cancer	0.000523	0.0124	CbGeAlD
Nicardipine—CHRM1—lung—hematologic cancer	0.000497	0.0118	CbGeAlD
Nicardipine—CALM2—blood—hematologic cancer	0.000497	0.0118	CbGeAlD
Nicardipine—CALM1—blood—hematologic cancer	0.000494	0.0117	CbGeAlD
Nicardipine—CACNA1D—lymph node—hematologic cancer	0.00049	0.0116	CbGeAlD
Nicardipine—CALM2—bone marrow—hematologic cancer	0.00048	0.0114	CbGeAlD
Nicardipine—CALM1—bone marrow—hematologic cancer	0.000478	0.0113	CbGeAlD
Nicardipine—CYP2C19—blood—hematologic cancer	0.000471	0.0112	CbGeAlD
Nicardipine—ADRA1A—blood—hematologic cancer	0.000466	0.011	CbGeAlD
Nicardipine—CACNA1C—lymph node—hematologic cancer	0.000453	0.0107	CbGeAlD
Nicardipine—CALM2—lung—hematologic cancer	0.000435	0.0103	CbGeAlD
Nicardipine—CALM1—lung—hematologic cancer	0.000433	0.0103	CbGeAlD
Nicardipine—CYP2B6—gonad—hematologic cancer	0.000424	0.01	CbGeAlD
Nicardipine—CYP3A4—hematopoietic system—hematologic cancer	0.000421	0.00997	CbGeAlD
Nicardipine—CHRM3—testis—hematologic cancer	0.00042	0.00994	CbGeAlD
Nicardipine—CYP2D6—hematopoietic system—hematologic cancer	0.000414	0.00981	CbGeAlD
Nicardipine—CYP2C8—blood—hematologic cancer	0.000412	0.00975	CbGeAlD
Nicardipine—CALM2—testis—hematologic cancer	0.000411	0.00973	CbGeAlD
Nicardipine—CALM1—testis—hematologic cancer	0.000409	0.00969	CbGeAlD
Nicardipine—CALM3—lymph node—hematologic cancer	0.000379	0.00898	CbGeAlD
Nicardipine—CYP3A5—blood—hematologic cancer	0.000371	0.0088	CbGeAlD
Nicardipine—CYP2B6—blood—hematologic cancer	0.000369	0.00875	CbGeAlD
Nicardipine—CYP2C9—blood—hematologic cancer	0.000366	0.00866	CbGeAlD
Nicardipine—CYP2E1—blood—hematologic cancer	0.000346	0.00821	CbGeAlD
Nicardipine—CYP2C8—testis—hematologic cancer	0.00034	0.00807	CbGeAlD
Nicardipine—CYP3A5—lung—hematologic cancer	0.000326	0.00771	CbGeAlD
Nicardipine—CYP2B6—lung—hematologic cancer	0.000324	0.00767	CbGeAlD
Nicardipine—CYP2B6—testis—hematologic cancer	0.000305	0.00723	CbGeAlD
Nicardipine—CYP2E1—lung—hematologic cancer	0.000304	0.0072	CbGeAlD
Nicardipine—Nifedipine—ABCC3—hematologic cancer	0.000299	0.459	CrCbGaD
Nicardipine—ABCB1—hematopoietic system—hematologic cancer	0.000298	0.00706	CbGeAlD
Nicardipine—CALM2—lymph node—hematologic cancer	0.000298	0.00705	CbGeAlD
Nicardipine—CALM1—lymph node—hematologic cancer	0.000296	0.00702	CbGeAlD
Nicardipine—CYP2E1—testis—hematologic cancer	0.000287	0.00679	CbGeAlD
Nicardipine—CYP3A4—blood—hematologic cancer	0.000279	0.0066	CbGeAlD
Nicardipine—CYP2D6—blood—hematologic cancer	0.000274	0.0065	CbGeAlD
Nicardipine—CYP2D6—testis—hematologic cancer	0.000227	0.00538	CbGeAlD
Nicardipine—ABCB1—gonad—hematologic cancer	0.000226	0.00537	CbGeAlD
Nicardipine—ABCB1—blood—hematologic cancer	0.000197	0.00468	CbGeAlD
Nicardipine—ABCB1—bone marrow—hematologic cancer	0.000191	0.00452	CbGeAlD
Nicardipine—ABCB1—lung—hematologic cancer	0.000173	0.0041	CbGeAlD
Nicardipine—ABCB1—testis—hematologic cancer	0.000163	0.00387	CbGeAlD
Nicardipine—ABCB1—lymph node—hematologic cancer	0.000118	0.0028	CbGeAlD
Nicardipine—Nisoldipine—ABCB1—hematologic cancer	8.38e-05	0.129	CrCbGaD
Nicardipine—Nitrendipine—ABCB1—hematologic cancer	7.84e-05	0.12	CrCbGaD
Nicardipine—Amlodipine—ABCB1—hematologic cancer	6.75e-05	0.104	CrCbGaD
Nicardipine—Felodipine—ABCB1—hematologic cancer	6.24e-05	0.0959	CrCbGaD
Nicardipine—Nifedipine—ABCB1—hematologic cancer	6.04e-05	0.0927	CrCbGaD
Nicardipine—Headache—Vincristine—hematologic cancer	3.92e-05	0.000185	CcSEcCtD
Nicardipine—Loss of consciousness—Prednisone—hematologic cancer	3.91e-05	0.000184	CcSEcCtD
Nicardipine—Hypotension—Dexamethasone—hematologic cancer	3.9e-05	0.000184	CcSEcCtD
Nicardipine—Hypotension—Betamethasone—hematologic cancer	3.9e-05	0.000184	CcSEcCtD
Nicardipine—Nausea—Carmustine—hematologic cancer	3.89e-05	0.000184	CcSEcCtD
Nicardipine—Vomiting—Irinotecan—hematologic cancer	3.87e-05	0.000183	CcSEcCtD
Nicardipine—Vomiting—Mitoxantrone—hematologic cancer	3.87e-05	0.000183	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—hematologic cancer	3.87e-05	0.000182	CcSEcCtD
Nicardipine—Nausea—Alitretinoin—hematologic cancer	3.86e-05	0.000182	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—hematologic cancer	3.85e-05	0.000182	CcSEcCtD
Nicardipine—Hypertension—Prednisone—hematologic cancer	3.84e-05	0.000181	CcSEcCtD
Nicardipine—Rash—Mitoxantrone—hematologic cancer	3.84e-05	0.000181	CcSEcCtD
Nicardipine—Rash—Irinotecan—hematologic cancer	3.84e-05	0.000181	CcSEcCtD
Nicardipine—Dermatitis—Mitoxantrone—hematologic cancer	3.84e-05	0.000181	CcSEcCtD
Nicardipine—Dermatitis—Irinotecan—hematologic cancer	3.84e-05	0.000181	CcSEcCtD
Nicardipine—Headache—Irinotecan—hematologic cancer	3.82e-05	0.00018	CcSEcCtD
Nicardipine—Headache—Mitoxantrone—hematologic cancer	3.82e-05	0.00018	CcSEcCtD
Nicardipine—Nausea—Ifosfamide—hematologic cancer	3.81e-05	0.00018	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.8e-05	0.000179	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.8e-05	0.000179	CcSEcCtD
Nicardipine—Arthralgia—Prednisone—hematologic cancer	3.79e-05	0.000179	CcSEcCtD
Nicardipine—Myalgia—Prednisone—hematologic cancer	3.79e-05	0.000179	CcSEcCtD
Nicardipine—Feeling abnormal—Triamcinolone—hematologic cancer	3.79e-05	0.000179	CcSEcCtD
Nicardipine—Diarrhoea—Cisplatin—hematologic cancer	3.78e-05	0.000178	CcSEcCtD
Nicardipine—Anxiety—Prednisone—hematologic cancer	3.78e-05	0.000178	CcSEcCtD
Nicardipine—Vomiting—Gemcitabine—hematologic cancer	3.77e-05	0.000178	CcSEcCtD
Nicardipine—Insomnia—Betamethasone—hematologic cancer	3.77e-05	0.000178	CcSEcCtD
Nicardipine—Insomnia—Dexamethasone—hematologic cancer	3.77e-05	0.000178	CcSEcCtD
Nicardipine—Paraesthesia—Betamethasone—hematologic cancer	3.74e-05	0.000177	CcSEcCtD
Nicardipine—Paraesthesia—Dexamethasone—hematologic cancer	3.74e-05	0.000177	CcSEcCtD
Nicardipine—Discomfort—Prednisone—hematologic cancer	3.74e-05	0.000177	CcSEcCtD
Nicardipine—Rash—Gemcitabine—hematologic cancer	3.74e-05	0.000176	CcSEcCtD
Nicardipine—Dermatitis—Gemcitabine—hematologic cancer	3.74e-05	0.000176	CcSEcCtD
Nicardipine—Hypersensitivity—Etoposide—hematologic cancer	3.73e-05	0.000176	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—hematologic cancer	3.73e-05	0.000176	CcSEcCtD
Nicardipine—Headache—Gemcitabine—hematologic cancer	3.72e-05	0.000175	CcSEcCtD
Nicardipine—Nausea—Vincristine—hematologic cancer	3.72e-05	0.000175	CcSEcCtD
Nicardipine—Flushing—Epirubicin—hematologic cancer	3.71e-05	0.000175	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—hematologic cancer	3.71e-05	0.000175	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisolone—hematologic cancer	3.68e-05	0.000174	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—hematologic cancer	3.68e-05	0.000174	CcSEcCtD
Nicardipine—Dyspepsia—Betamethasone—hematologic cancer	3.67e-05	0.000173	CcSEcCtD
Nicardipine—Dyspepsia—Dexamethasone—hematologic cancer	3.67e-05	0.000173	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—hematologic cancer	3.64e-05	0.000172	CcSEcCtD
Nicardipine—Asthenia—Etoposide—hematologic cancer	3.64e-05	0.000171	CcSEcCtD
Nicardipine—Body temperature increased—Triamcinolone—hematologic cancer	3.63e-05	0.000171	CcSEcCtD
Nicardipine—Oedema—Prednisone—hematologic cancer	3.63e-05	0.000171	CcSEcCtD
Nicardipine—Nausea—Mitoxantrone—hematologic cancer	3.62e-05	0.000171	CcSEcCtD
Nicardipine—Nausea—Irinotecan—hematologic cancer	3.62e-05	0.000171	CcSEcCtD
Nicardipine—Infection—Prednisone—hematologic cancer	3.61e-05	0.00017	CcSEcCtD
Nicardipine—Shock—Prednisone—hematologic cancer	3.57e-05	0.000168	CcSEcCtD
Nicardipine—Pain—Dexamethasone—hematologic cancer	3.57e-05	0.000168	CcSEcCtD
Nicardipine—Pain—Betamethasone—hematologic cancer	3.57e-05	0.000168	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—hematologic cancer	3.56e-05	0.000168	CcSEcCtD
Nicardipine—Tachycardia—Prednisone—hematologic cancer	3.54e-05	0.000167	CcSEcCtD
Nicardipine—Nausea—Gemcitabine—hematologic cancer	3.52e-05	0.000166	CcSEcCtD
Nicardipine—Vomiting—Cisplatin—hematologic cancer	3.52e-05	0.000166	CcSEcCtD
Nicardipine—Hyperhidrosis—Prednisone—hematologic cancer	3.51e-05	0.000166	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—hematologic cancer	3.5e-05	0.000165	CcSEcCtD
Nicardipine—Rash—Cisplatin—hematologic cancer	3.49e-05	0.000164	CcSEcCtD
Nicardipine—Dermatitis—Cisplatin—hematologic cancer	3.48e-05	0.000164	CcSEcCtD
Nicardipine—Diarrhoea—Etoposide—hematologic cancer	3.47e-05	0.000163	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—hematologic cancer	3.45e-05	0.000163	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—hematologic cancer	3.45e-05	0.000163	CcSEcCtD
Nicardipine—Feeling abnormal—Dexamethasone—hematologic cancer	3.44e-05	0.000162	CcSEcCtD
Nicardipine—Feeling abnormal—Betamethasone—hematologic cancer	3.44e-05	0.000162	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—hematologic cancer	3.43e-05	0.000162	CcSEcCtD
Nicardipine—Tension—Epirubicin—hematologic cancer	3.41e-05	0.000161	CcSEcCtD
Nicardipine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.41e-05	0.000161	CcSEcCtD
Nicardipine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.41e-05	0.000161	CcSEcCtD
Nicardipine—Hypersensitivity—Triamcinolone—hematologic cancer	3.39e-05	0.00016	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—hematologic cancer	3.38e-05	0.000159	CcSEcCtD
Nicardipine—Malaise—Methotrexate—hematologic cancer	3.35e-05	0.000158	CcSEcCtD
Nicardipine—Dizziness—Etoposide—hematologic cancer	3.35e-05	0.000158	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—hematologic cancer	3.34e-05	0.000158	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.31e-05	0.000156	CcSEcCtD
Nicardipine—Dizziness—Prednisolone—hematologic cancer	3.3e-05	0.000156	CcSEcCtD
Nicardipine—Asthenia—Triamcinolone—hematologic cancer	3.3e-05	0.000155	CcSEcCtD
Nicardipine—Abdominal pain—Dexamethasone—hematologic cancer	3.3e-05	0.000155	CcSEcCtD
Nicardipine—Body temperature increased—Dexamethasone—hematologic cancer	3.3e-05	0.000155	CcSEcCtD
Nicardipine—Body temperature increased—Betamethasone—hematologic cancer	3.3e-05	0.000155	CcSEcCtD
Nicardipine—Abdominal pain—Betamethasone—hematologic cancer	3.3e-05	0.000155	CcSEcCtD
Nicardipine—Nausea—Cisplatin—hematologic cancer	3.29e-05	0.000155	CcSEcCtD
Nicardipine—Insomnia—Prednisone—hematologic cancer	3.28e-05	0.000155	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—hematologic cancer	3.28e-05	0.000155	CcSEcCtD
Nicardipine—Paraesthesia—Prednisone—hematologic cancer	3.26e-05	0.000154	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—hematologic cancer	3.23e-05	0.000152	CcSEcCtD
Nicardipine—Vomiting—Etoposide—hematologic cancer	3.22e-05	0.000152	CcSEcCtD
Nicardipine—Agitation—Epirubicin—hematologic cancer	3.2e-05	0.000151	CcSEcCtD
Nicardipine—Dyspepsia—Prednisone—hematologic cancer	3.2e-05	0.000151	CcSEcCtD
Nicardipine—Rash—Etoposide—hematologic cancer	3.19e-05	0.000151	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—hematologic cancer	3.19e-05	0.000151	CcSEcCtD
Nicardipine—Headache—Etoposide—hematologic cancer	3.17e-05	0.00015	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—hematologic cancer	3.17e-05	0.000149	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—hematologic cancer	3.17e-05	0.000149	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—hematologic cancer	3.17e-05	0.000149	CcSEcCtD
Nicardipine—Tension—Doxorubicin—hematologic cancer	3.16e-05	0.000149	CcSEcCtD
Nicardipine—Rash—Prednisolone—hematologic cancer	3.15e-05	0.000149	CcSEcCtD
Nicardipine—Dermatitis—Prednisolone—hematologic cancer	3.15e-05	0.000148	CcSEcCtD
Nicardipine—Malaise—Epirubicin—hematologic cancer	3.14e-05	0.000148	CcSEcCtD
Nicardipine—Headache—Prednisolone—hematologic cancer	3.13e-05	0.000148	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—hematologic cancer	3.13e-05	0.000148	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—hematologic cancer	3.13e-05	0.000147	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—hematologic cancer	3.13e-05	0.000147	CcSEcCtD
Nicardipine—Syncope—Epirubicin—hematologic cancer	3.12e-05	0.000147	CcSEcCtD
Nicardipine—Constipation—Prednisone—hematologic cancer	3.11e-05	0.000146	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—hematologic cancer	3.08e-05	0.000145	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—hematologic cancer	3.06e-05	0.000144	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—hematologic cancer	3.06e-05	0.000144	CcSEcCtD
Nicardipine—Dizziness—Triamcinolone—hematologic cancer	3.04e-05	0.000143	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—hematologic cancer	3.03e-05	0.000143	CcSEcCtD
Nicardipine—Infection—Methotrexate—hematologic cancer	3.02e-05	0.000142	CcSEcCtD
Nicardipine—Nausea—Etoposide—hematologic cancer	3.01e-05	0.000142	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—hematologic cancer	3e-05	0.000142	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisone—hematologic cancer	2.99e-05	0.000141	CcSEcCtD
Nicardipine—Asthenia—Betamethasone—hematologic cancer	2.99e-05	0.000141	CcSEcCtD
Nicardipine—Asthenia—Dexamethasone—hematologic cancer	2.99e-05	0.000141	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.99e-05	0.000141	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—hematologic cancer	2.97e-05	0.00014	CcSEcCtD
Nicardipine—Gastrointestinal pain—Prednisone—hematologic cancer	2.97e-05	0.00014	CcSEcCtD
Nicardipine—Nausea—Prednisolone—hematologic cancer	2.97e-05	0.00014	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—hematologic cancer	2.96e-05	0.00014	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—hematologic cancer	2.96e-05	0.00014	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—hematologic cancer	2.96e-05	0.00014	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—hematologic cancer	2.96e-05	0.00014	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—hematologic cancer	2.95e-05	0.000139	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—hematologic cancer	2.93e-05	0.000138	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—hematologic cancer	2.93e-05	0.000138	CcSEcCtD
Nicardipine—Vomiting—Triamcinolone—hematologic cancer	2.92e-05	0.000138	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—hematologic cancer	2.9e-05	0.000137	CcSEcCtD
Nicardipine—Rash—Triamcinolone—hematologic cancer	2.9e-05	0.000137	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—hematologic cancer	2.9e-05	0.000137	CcSEcCtD
Nicardipine—Dermatitis—Triamcinolone—hematologic cancer	2.89e-05	0.000137	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—hematologic cancer	2.89e-05	0.000136	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—hematologic cancer	2.89e-05	0.000136	CcSEcCtD
Nicardipine—Headache—Triamcinolone—hematologic cancer	2.88e-05	0.000136	CcSEcCtD
Nicardipine—Body temperature increased—Prednisone—hematologic cancer	2.87e-05	0.000135	CcSEcCtD
Nicardipine—Abdominal pain—Prednisone—hematologic cancer	2.87e-05	0.000135	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—hematologic cancer	2.86e-05	0.000135	CcSEcCtD
Nicardipine—Diarrhoea—Dexamethasone—hematologic cancer	2.85e-05	0.000135	CcSEcCtD
Nicardipine—Diarrhoea—Betamethasone—hematologic cancer	2.85e-05	0.000135	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—hematologic cancer	2.85e-05	0.000134	CcSEcCtD
Nicardipine—Oedema—Epirubicin—hematologic cancer	2.84e-05	0.000134	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—hematologic cancer	2.84e-05	0.000134	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—hematologic cancer	2.83e-05	0.000133	CcSEcCtD
Nicardipine—Infection—Epirubicin—hematologic cancer	2.82e-05	0.000133	CcSEcCtD
Nicardipine—Shock—Epirubicin—hematologic cancer	2.79e-05	0.000132	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—hematologic cancer	2.78e-05	0.000131	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—hematologic cancer	2.78e-05	0.000131	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—hematologic cancer	2.77e-05	0.000131	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.77e-05	0.00013	CcSEcCtD
Nicardipine—Dizziness—Dexamethasone—hematologic cancer	2.76e-05	0.00013	CcSEcCtD
Nicardipine—Dizziness—Betamethasone—hematologic cancer	2.76e-05	0.00013	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—hematologic cancer	2.75e-05	0.000129	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—hematologic cancer	2.74e-05	0.000129	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—hematologic cancer	2.74e-05	0.000129	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—hematologic cancer	2.74e-05	0.000129	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—hematologic cancer	2.74e-05	0.000129	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—hematologic cancer	2.73e-05	0.000129	CcSEcCtD
Nicardipine—Nausea—Triamcinolone—hematologic cancer	2.73e-05	0.000129	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—hematologic cancer	2.73e-05	0.000129	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—hematologic cancer	2.71e-05	0.000128	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—hematologic cancer	2.71e-05	0.000128	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—hematologic cancer	2.7e-05	0.000127	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—hematologic cancer	2.68e-05	0.000126	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisone—hematologic cancer	2.68e-05	0.000126	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—hematologic cancer	2.67e-05	0.000126	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—hematologic cancer	2.65e-05	0.000125	CcSEcCtD
Nicardipine—Vomiting—Betamethasone—hematologic cancer	2.65e-05	0.000125	CcSEcCtD
Nicardipine—Vomiting—Dexamethasone—hematologic cancer	2.65e-05	0.000125	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—hematologic cancer	2.65e-05	0.000125	CcSEcCtD
Nicardipine—Rash—Dexamethasone—hematologic cancer	2.63e-05	0.000124	CcSEcCtD
Nicardipine—Rash—Betamethasone—hematologic cancer	2.63e-05	0.000124	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—hematologic cancer	2.63e-05	0.000124	CcSEcCtD
Nicardipine—Dermatitis—Dexamethasone—hematologic cancer	2.63e-05	0.000124	CcSEcCtD
Nicardipine—Dermatitis—Betamethasone—hematologic cancer	2.63e-05	0.000124	CcSEcCtD
Nicardipine—Headache—Dexamethasone—hematologic cancer	2.61e-05	0.000123	CcSEcCtD
Nicardipine—Headache—Betamethasone—hematologic cancer	2.61e-05	0.000123	CcSEcCtD
Nicardipine—Infection—Doxorubicin—hematologic cancer	2.61e-05	0.000123	CcSEcCtD
Nicardipine—Asthenia—Prednisone—hematologic cancer	2.61e-05	0.000123	CcSEcCtD
Nicardipine—Pain—Methotrexate—hematologic cancer	2.6e-05	0.000122	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.59e-05	0.000122	CcSEcCtD
Nicardipine—Shock—Doxorubicin—hematologic cancer	2.59e-05	0.000122	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.57e-05	0.000121	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—hematologic cancer	2.57e-05	0.000121	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—hematologic cancer	2.56e-05	0.000121	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—hematologic cancer	2.55e-05	0.00012	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.54e-05	0.00012	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—hematologic cancer	2.53e-05	0.000119	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—hematologic cancer	2.52e-05	0.000119	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—hematologic cancer	2.5e-05	0.000118	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—hematologic cancer	2.5e-05	0.000118	CcSEcCtD
Nicardipine—Diarrhoea—Prednisone—hematologic cancer	2.48e-05	0.000117	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.48e-05	0.000117	CcSEcCtD
Nicardipine—Nausea—Dexamethasone—hematologic cancer	2.48e-05	0.000117	CcSEcCtD
Nicardipine—Nausea—Betamethasone—hematologic cancer	2.48e-05	0.000117	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—hematologic cancer	2.46e-05	0.000116	CcSEcCtD
Nicardipine—Pain—Epirubicin—hematologic cancer	2.43e-05	0.000115	CcSEcCtD
Nicardipine—Constipation—Epirubicin—hematologic cancer	2.43e-05	0.000115	CcSEcCtD
Nicardipine—Dizziness—Prednisone—hematologic cancer	2.4e-05	0.000113	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—hematologic cancer	2.4e-05	0.000113	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—hematologic cancer	2.4e-05	0.000113	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.39e-05	0.000113	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—hematologic cancer	2.38e-05	0.000112	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—hematologic cancer	2.36e-05	0.000111	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—hematologic cancer	2.34e-05	0.00011	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—hematologic cancer	2.34e-05	0.00011	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—hematologic cancer	2.34e-05	0.00011	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.32e-05	0.00011	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—hematologic cancer	2.31e-05	0.000109	CcSEcCtD
Nicardipine—Vomiting—Prednisone—hematologic cancer	2.31e-05	0.000109	CcSEcCtD
Nicardipine—Rash—Prednisone—hematologic cancer	2.29e-05	0.000108	CcSEcCtD
Nicardipine—Dermatitis—Prednisone—hematologic cancer	2.29e-05	0.000108	CcSEcCtD
Nicardipine—Headache—Prednisone—hematologic cancer	2.27e-05	0.000107	CcSEcCtD
Nicardipine—Pain—Doxorubicin—hematologic cancer	2.25e-05	0.000106	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—hematologic cancer	2.25e-05	0.000106	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—hematologic cancer	2.25e-05	0.000106	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—hematologic cancer	2.25e-05	0.000106	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—hematologic cancer	2.24e-05	0.000105	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—hematologic cancer	2.18e-05	0.000103	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—hematologic cancer	2.17e-05	0.000102	CcSEcCtD
Nicardipine—Nausea—Prednisone—hematologic cancer	2.16e-05	0.000102	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.15e-05	0.000101	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—hematologic cancer	2.09e-05	9.87e-05	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—hematologic cancer	2.08e-05	9.8e-05	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—hematologic cancer	2.08e-05	9.8e-05	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—hematologic cancer	2.08e-05	9.79e-05	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—hematologic cancer	2.04e-05	9.61e-05	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—hematologic cancer	2.01e-05	9.46e-05	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—hematologic cancer	1.94e-05	9.16e-05	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—hematologic cancer	1.94e-05	9.13e-05	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—hematologic cancer	1.93e-05	9.1e-05	CcSEcCtD
Nicardipine—Rash—Methotrexate—hematologic cancer	1.91e-05	9.02e-05	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—hematologic cancer	1.91e-05	9.02e-05	CcSEcCtD
Nicardipine—Headache—Methotrexate—hematologic cancer	1.9e-05	8.97e-05	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—hematologic cancer	1.89e-05	8.89e-05	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—hematologic cancer	1.88e-05	8.86e-05	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—hematologic cancer	1.81e-05	8.52e-05	CcSEcCtD
Nicardipine—Nausea—Methotrexate—hematologic cancer	1.8e-05	8.5e-05	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—hematologic cancer	1.8e-05	8.48e-05	CcSEcCtD
Nicardipine—Rash—Epirubicin—hematologic cancer	1.79e-05	8.45e-05	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—hematologic cancer	1.79e-05	8.44e-05	CcSEcCtD
Nicardipine—Headache—Epirubicin—hematologic cancer	1.78e-05	8.39e-05	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—hematologic cancer	1.74e-05	8.2e-05	CcSEcCtD
Nicardipine—Nausea—Epirubicin—hematologic cancer	1.69e-05	7.96e-05	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—hematologic cancer	1.67e-05	7.88e-05	CcSEcCtD
Nicardipine—Rash—Doxorubicin—hematologic cancer	1.66e-05	7.81e-05	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—hematologic cancer	1.66e-05	7.81e-05	CcSEcCtD
Nicardipine—Headache—Doxorubicin—hematologic cancer	1.65e-05	7.76e-05	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—hematologic cancer	1.56e-05	7.36e-05	CcSEcCtD
Nicardipine—CALM2—Immune System—KRAS—hematologic cancer	8.69e-07	5.06e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—hematologic cancer	8.69e-07	5.06e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—hematologic cancer	8.68e-07	5.06e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—hematologic cancer	8.68e-07	5.06e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—EP300—hematologic cancer	8.68e-07	5.06e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—EP300—hematologic cancer	8.66e-07	5.05e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—hematologic cancer	8.66e-07	5.04e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—hematologic cancer	8.66e-07	5.04e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EP300—hematologic cancer	8.64e-07	5.03e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—EP300—hematologic cancer	8.63e-07	5.02e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EP300—hematologic cancer	8.62e-07	5.02e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3R1—hematologic cancer	8.6e-07	5e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—hematologic cancer	8.59e-07	5e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NCOR1—hematologic cancer	8.59e-07	5e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	8.58e-07	5e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	8.58e-07	4.99e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	8.54e-07	4.97e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EP300—hematologic cancer	8.53e-07	4.97e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	8.51e-07	4.95e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	8.5e-07	4.95e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MTOR—hematologic cancer	8.47e-07	4.93e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MTOR—hematologic cancer	8.47e-07	4.93e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	8.47e-07	4.93e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	8.47e-07	4.93e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—hematologic cancer	8.47e-07	4.93e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—hematologic cancer	8.41e-07	4.89e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—hematologic cancer	8.4e-07	4.89e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—hematologic cancer	8.4e-07	4.89e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—hematologic cancer	8.39e-07	4.89e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—hematologic cancer	8.38e-07	4.88e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—hematologic cancer	8.36e-07	4.87e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	8.35e-07	4.86e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—EP300—hematologic cancer	8.35e-07	4.86e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—EP300—hematologic cancer	8.35e-07	4.86e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	8.33e-07	4.85e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—hematologic cancer	8.3e-07	4.83e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—hematologic cancer	8.29e-07	4.83e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	8.27e-07	4.82e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	8.26e-07	4.81e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—hematologic cancer	8.25e-07	4.81e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	8.21e-07	4.78e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	8.19e-07	4.77e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	8.16e-07	4.75e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	8.13e-07	4.73e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	8.11e-07	4.72e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	8.1e-07	4.72e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	8.09e-07	4.71e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—hematologic cancer	8.08e-07	4.71e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—hematologic cancer	8.08e-07	4.71e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	8.08e-07	4.71e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	8.08e-07	4.7e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	8.06e-07	4.69e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	8.06e-07	4.69e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—hematologic cancer	8.05e-07	4.69e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—hematologic cancer	8.04e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—hematologic cancer	8.04e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	8.03e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—hematologic cancer	8.02e-07	4.67e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—hematologic cancer	8.02e-07	4.67e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	8e-07	4.66e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—hematologic cancer	8e-07	4.66e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—hematologic cancer	7.98e-07	4.65e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—hematologic cancer	7.98e-07	4.65e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	7.98e-07	4.65e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	7.98e-07	4.65e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	7.96e-07	4.64e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	7.95e-07	4.63e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	7.95e-07	4.63e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—hematologic cancer	7.93e-07	4.62e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	7.9e-07	4.6e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—hematologic cancer	7.87e-07	4.58e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—hematologic cancer	7.84e-07	4.56e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—JUN—hematologic cancer	7.82e-07	4.55e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—hematologic cancer	7.79e-07	4.54e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—hematologic cancer	7.79e-07	4.54e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—hematologic cancer	7.78e-07	4.53e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—hematologic cancer	7.78e-07	4.53e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—hematologic cancer	7.75e-07	4.51e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	7.74e-07	4.51e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—hematologic cancer	7.74e-07	4.51e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—hematologic cancer	7.74e-07	4.51e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	7.72e-07	4.49e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	7.71e-07	4.49e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	7.64e-07	4.45e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—hematologic cancer	7.64e-07	4.45e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	7.62e-07	4.44e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—hematologic cancer	7.62e-07	4.44e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—hematologic cancer	7.62e-07	4.44e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—hematologic cancer	7.59e-07	4.42e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	7.58e-07	4.41e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—hematologic cancer	7.58e-07	4.41e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—hematologic cancer	7.58e-07	4.41e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—JUN—hematologic cancer	7.56e-07	4.4e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—JUN—hematologic cancer	7.56e-07	4.4e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—hematologic cancer	7.56e-07	4.4e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	7.56e-07	4.4e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—hematologic cancer	7.53e-07	4.39e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	7.51e-07	4.38e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—hematologic cancer	7.51e-07	4.37e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—EP300—hematologic cancer	7.5e-07	4.37e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	7.49e-07	4.36e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	7.48e-07	4.35e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—hematologic cancer	7.44e-07	4.33e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—hematologic cancer	7.42e-07	4.32e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	7.42e-07	4.32e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	7.41e-07	4.32e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	7.41e-07	4.32e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK8—hematologic cancer	7.4e-07	4.31e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	7.4e-07	4.31e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—hematologic cancer	7.39e-07	4.3e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—hematologic cancer	7.39e-07	4.3e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—hematologic cancer	7.38e-07	4.3e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—hematologic cancer	7.37e-07	4.29e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—hematologic cancer	7.37e-07	4.29e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	7.33e-07	4.27e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	7.33e-07	4.27e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—hematologic cancer	7.32e-07	4.26e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—hematologic cancer	7.32e-07	4.26e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—hematologic cancer	7.31e-07	4.26e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EP300—hematologic cancer	7.21e-07	4.2e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK8—hematologic cancer	7.16e-07	4.17e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK8—hematologic cancer	7.16e-07	4.17e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—hematologic cancer	7.14e-07	4.16e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—hematologic cancer	7.14e-07	4.16e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	7.09e-07	4.13e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—hematologic cancer	7.07e-07	4.12e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—hematologic cancer	7.07e-07	4.12e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—hematologic cancer	7.05e-07	4.11e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—hematologic cancer	7.02e-07	4.09e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—hematologic cancer	7.01e-07	4.08e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EP300—hematologic cancer	6.98e-07	4.06e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EP300—hematologic cancer	6.98e-07	4.06e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	6.97e-07	4.06e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	6.96e-07	4.05e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	6.94e-07	4.04e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	6.87e-07	4e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—hematologic cancer	6.86e-07	3.99e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	6.86e-07	3.99e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	6.85e-07	3.99e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—hematologic cancer	6.83e-07	3.98e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—hematologic cancer	6.82e-07	3.97e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—hematologic cancer	6.82e-07	3.97e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—hematologic cancer	6.79e-07	3.95e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—hematologic cancer	6.79e-07	3.95e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—hematologic cancer	6.76e-07	3.94e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—hematologic cancer	6.75e-07	3.93e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—hematologic cancer	6.75e-07	3.93e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—hematologic cancer	6.74e-07	3.93e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—EP300—hematologic cancer	6.7e-07	3.9e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—hematologic cancer	6.61e-07	3.85e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—hematologic cancer	6.61e-07	3.85e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	6.56e-07	3.82e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	6.56e-07	3.82e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—hematologic cancer	6.54e-07	3.81e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—hematologic cancer	6.54e-07	3.81e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—EP300—hematologic cancer	6.54e-07	3.81e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—hematologic cancer	6.53e-07	3.8e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—hematologic cancer	6.53e-07	3.8e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—hematologic cancer	6.53e-07	3.8e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—hematologic cancer	6.53e-07	3.8e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—hematologic cancer	6.52e-07	3.8e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—hematologic cancer	6.52e-07	3.8e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK3—hematologic cancer	6.46e-07	3.76e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—hematologic cancer	6.46e-07	3.76e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	6.42e-07	3.74e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	6.41e-07	3.73e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—hematologic cancer	6.4e-07	3.73e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	6.39e-07	3.72e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—hematologic cancer	6.38e-07	3.72e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.38e-07	3.71e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	6.37e-07	3.71e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	6.31e-07	3.68e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	6.29e-07	3.67e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—hematologic cancer	6.29e-07	3.66e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	6.27e-07	3.65e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—hematologic cancer	6.27e-07	3.65e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK3—hematologic cancer	6.25e-07	3.64e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK3—hematologic cancer	6.25e-07	3.64e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—hematologic cancer	6.23e-07	3.63e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—hematologic cancer	6.23e-07	3.62e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—hematologic cancer	6.19e-07	3.6e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—hematologic cancer	6.17e-07	3.59e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—hematologic cancer	6.17e-07	3.59e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—hematologic cancer	6.17e-07	3.59e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—EP300—hematologic cancer	6.16e-07	3.59e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—EP300—hematologic cancer	6.11e-07	3.56e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—hematologic cancer	6.11e-07	3.56e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	6.09e-07	3.55e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—hematologic cancer	6.08e-07	3.54e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—hematologic cancer	6.08e-07	3.54e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—hematologic cancer	6.07e-07	3.53e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—hematologic cancer	6.07e-07	3.53e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—hematologic cancer	6.02e-07	3.51e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—hematologic cancer	6.02e-07	3.51e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	5.92e-07	3.44e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CREBBP—hematologic cancer	5.91e-07	3.44e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	5.9e-07	3.43e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	5.84e-07	3.4e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	5.82e-07	3.39e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—hematologic cancer	5.81e-07	3.38e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	5.79e-07	3.37e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—hematologic cancer	5.66e-07	3.3e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—hematologic cancer	5.64e-07	3.29e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—hematologic cancer	5.62e-07	3.27e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—hematologic cancer	5.62e-07	3.27e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.61e-07	3.27e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—hematologic cancer	5.59e-07	3.25e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	5.57e-07	3.25e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	5.55e-07	3.23e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—hematologic cancer	5.54e-07	3.22e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—hematologic cancer	5.36e-07	3.12e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	5.34e-07	3.11e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.3e-07	3.08e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—hematologic cancer	5.25e-07	3.06e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—hematologic cancer	5.24e-07	3.05e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	5.22e-07	3.04e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—hematologic cancer	5.21e-07	3.04e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	5.21e-07	3.03e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—hematologic cancer	5.16e-07	3.01e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	5.16e-07	3.01e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	5.16e-07	3.01e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.16e-07	3e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	5.14e-07	2.99e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—hematologic cancer	5.04e-07	2.94e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—hematologic cancer	5.04e-07	2.94e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—hematologic cancer	4.99e-07	2.91e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—hematologic cancer	4.99e-07	2.91e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	4.96e-07	2.89e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—hematologic cancer	4.94e-07	2.87e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.89e-07	2.85e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—hematologic cancer	4.84e-07	2.82e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—hematologic cancer	4.78e-07	2.78e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—hematologic cancer	4.78e-07	2.78e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—hematologic cancer	4.73e-07	2.75e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—hematologic cancer	4.57e-07	2.66e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—hematologic cancer	4.57e-07	2.66e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	4.56e-07	2.65e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—hematologic cancer	4.54e-07	2.64e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.52e-07	2.63e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—hematologic cancer	4.36e-07	2.54e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—hematologic cancer	4.22e-07	2.46e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—hematologic cancer	4.22e-07	2.46e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—hematologic cancer	4.22e-07	2.46e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—hematologic cancer	4.05e-07	2.36e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—EP300—hematologic cancer	4.03e-07	2.35e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—hematologic cancer	3.95e-07	2.3e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—hematologic cancer	3.72e-07	2.17e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—hematologic cancer	3.69e-07	2.15e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.98e-07	1.74e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—hematologic cancer	2.43e-07	1.42e-06	CbGpPWpGaD
